突发性心脏损伤的分子生物标志物:最近的进展和未来的前景
Ning Wang1,2, Jiliang Huang3, Ying Fang1,2
1Department of Forensic Pathology, Zhongshan School of Medicine Sun Yat-sen University, Guangzhou, Guangdong, China.
Expert review of molecular diagnostics
|September 17, 2024
概括
确定突发心脏损伤 (BCI) 的特定分子生物标志物对于改善诊断和患者护理至关重要. 本综述总结了当前的生物标志物,如热波宁和NT-proBNP,强调了未来的研究需求.
科学领域:
- 心血管医学中的生物标志物
- 创伤和急诊医学研究研究.
- 在心脏损伤中的分子诊断.
背景情况:
- 体心脏损伤 (BCI) 给患病率和死亡率带来了重大挑战.
- 目前的诊断方法缺乏普遍接受的黄金标准.
- 对BCI的分子生物标志物正在开发中,尚未成为标准的临床实践.
研究的目的:
- 审查和总结现有的突发心脏损伤 (BCI) 的分子生物标志物.
- 突出识别特定生物标志物的重要性,以改善BCI诊断.
- 为BCI诊断生物标志物提供未来研究方向的见解.
主要方法:
- 2004年6月至2024年6月在PubMed和CNKI上的论文的系统文献综述.
- 搜索术语包括"生物标志物"和"急性心脏损伤".
- 分析和总结了20个选择的研究报告BCI生物标志物.
主要成果:
- 讨论的关键分子生物标志物包括热波宁,N终端proB型尿素 (NT-proBNP),心型脂肪酸结合蛋白 (hFABP) 和乳酸.
- 这些生物标志物显示出改善BCI诊断的潜力.
- 该审查巩固了目前关于BCI确定生物标志物的知识.
结论:
- 特定的分子生物标志物对于推进BCI诊断和患者管理至关重要.
- 需要进一步的研究来验证和在临床环境中实施这些生物标志物.
- 已识别的生物标志物为BCI患者提供了更精确和及时的护理的基础.
更多相关视频
08:14Capturing the Cardiac Injury Response of Targeted Cell Populations via Cleared Heart Three-Dimensional Imaging
Published on: March 17, 2020
5.9K
14:35Post-Myocardial Infarction Heart Failure in Closed-chest Coronary Occlusion/Reperfusion Model in Göttingen Minipigs and Landrace Pigs
Published on: April 17, 2021
8.5K
相关概念视频
01:20Blood Studies for Cardiovascular System I: Cardiac Biomarkers
110
Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
110
01:19Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers
64
Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
64